State of the union between cognitive neuroscience and emotion

Waisman Laboratory for Brain Imaging & Behavior, Departments of Psychiatry & Psychology, University of Wisconsin-Madison, Waisman Center, 1500 Highland Avenue, Madison, WI 53705, USA.
Expert Review of Neurotherapeutics (Impact Factor: 2.78). 08/2008; 8(7):1025-7. DOI: 10.1586/14737175.8.7.1025
Source: PubMed


The 15th Annual Meeting of the Cognitive Neuroscience Society brought together researchers and exhibitors to discuss and present data relevant to the study of the mind using neuroscience methods, especially neuroimaging. A history of interdisciplinary communication, which was the basis of the creation of this society, continues to expand the scope of work presented at the meeting to include research on emotional and social processes as well as various forms of psychopathology. Neurotherapeutics and individual differences in treatment responsivity may be on the horizon.

Download full-text


Available from: Desmond J Oathes, Oct 04, 2015
9 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Functional magnetic resonance imaging (fMRI) holds promise as a noninvasive means of identifying neural responses that can be used to predict treatment response before beginning a drug trial. Imaging paradigms employing facial expressions as presented stimuli have been shown to activate the amygdala and anterior cingulate cortex (ACC). Here, we sought to determine whether pretreatment amygdala and rostral ACC (rACC) reactivity to facial expressions could predict treatment outcomes in patients with generalized anxiety disorder (GAD). Fifteen subjects (12 female subjects) with GAD participated in an open-label venlafaxine treatment trial. Functional magnetic resonance imaging responses to facial expressions of emotion collected before subjects began treatment were compared with changes in anxiety following 8 weeks of venlafaxine administration. In addition, the magnitude of fMRI responses of subjects with GAD were compared with that of 15 control subjects (12 female subjects) who did not have GAD and did not receive venlafaxine treatment. The magnitude of treatment response was predicted by greater pretreatment reactivity to fearful faces in rACC and lesser reactivity in the amygdala. These individual differences in pretreatment rACC and amygdala reactivity within the GAD group were observed despite the fact that 1) the overall magnitude of pretreatment rACC and amygdala reactivity did not differ between subjects with GAD and control subjects and 2) there was no main effect of treatment on rACC-amygdala reactivity in the GAD group. These findings show that this pattern of rACC-amygdala responsivity could prove useful as a predictor of venlafaxine treatment response in patients with GAD.
    Biological psychiatry 06/2008; 63(9):858-63. DOI:10.1016/j.biopsych.2007.08.019 · 10.26 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Researchers have suggested that the right hemisphere is superior at processing emotional facial expressions because it contains stored perceptual 'templates' of facial expressions. We tested each hemisphere of a split-brain patient on two tasks involving emotional facial expressions. Both hemispheres performed equally well and significantly above chance matching facial expressions with emotion words. The subject's right hemisphere consistently performed well judging whether two facial expressions were the same or different. His left hemisphere performed poorly on this discrimination task at first, but showed a sharp improvement when the instructions were changed slightly, emphasizing verbal labels for the facial expressions. Results suggest that 'facial expression templates' may not be stored only on the right.
    Neuropsychologia 02/1996; 34(1):23-9. DOI:10.1016/0028-3932(95)00060-7 · 3.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The relationship between pretreatment regional cerebral glucose metabolism and eventual antidepressant drug response was measured using positron emission tomography (PET) in hospitalized patients with unipolar depression. Rostral anterior cingulate metabolism uniquely differentiated eventual treatment responders from non-responders. Hypometabolism characterized non-responders when compared with controls, in contrast to responders who were hypermetabolic. Metabolism in no other region discriminated the two groups, nor did associated demographic, clinical or behavioral measures, including motor speed, cognitive performance, depression severity or illness chronicity. Cingulate hypermetabolism may represent an important adaptive response to depression and failure of this response may underlie poor outcome. A critical role for rostral cingulate area 24a/b in the limbic-cortical network involved in abnormal mood states is proposed.
    Neuroreport 04/1997; 8(4):1057-61. · 1.52 Impact Factor